Overall market sentiment has been high on Curis, Inc. (CRIS) stock lately. CRIS receives a Bullish rating from InvestorsObserver's Stock Sentiment Indicator.
What is Stock Sentiment?
Sentiment is a very short-term indicator that is entirely technical. There is no information about the health of profitability of the underlying company in our sentiment score.
As a technical indicator, news about the stock, or company, such as an earnings release or other event, could move the stock counter to the recent trend.
Changes in price are generally the best indicator of sentiment for a particular stock. At its core, a stock's trend indicates whether current market sentiment is bullish or bearish. Investors must be bullish if a stock is trending upward, and are bearish if a stock is moving down.
InvestorsObserver's Sentiment Indicator factors in both price changes and variations in volume. An increase in volume usually means a current trend is stengthening, while a drop in volume tends to signal a reversal to the ongoing trend.
Our system also uses the options market in order to receive additional signals on current sentiments. We take into account the ratio of calls and puts for a stock since options allow an investor to bet on future changes in price.
What's Happening With CRIS Stock Today?
Curis, Inc. (CRIS) stock is trading at $11.80 as of 11:38 AM on Tuesday, Mar 23, a decline of -$0.97, or -7.6% from the previous closing price of $12.77. The stock has traded between $11.64 and $12.68 so far today. Volume today is below average. So far 1,138,255 shares have traded compared to average volume of 2,046,317 shares.
To see InvestorsObserver's Sentiment Score for Curis, Inc. click here.
More About Curis, Inc.
Curis Inc is a biotechnology company that develops and commercializes innovative drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, advanced solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.
Click Here to get the full Stock Score Report on Curis, Inc. (CRIS) Stock.